| Literature DB >> 28461738 |
Yuki Nakano1, Koichiro Manabe1, Rie Osaka1, Yukari Takasago1, Aoi Ono1, Mamoru Kobayashi1, Tomoyoshi Fujita1, Chieko Shiragami1, Kazuyuki Hirooka1, Akitaka Tsujikawa1.
Abstract
PURPOSE: To evaluate the effects of vitreomacular and cataract surgery on retinal oximetry in vitreomacular disease. PATIENTS AND METHODS: Thirty-eight eyes with epiretinal membrane (ERM) and 15 with idiopathic macular hole (MH) underwent 25 gauge pars plana vitrectomy combined with cataract surgery and intraocular lens implantation. Retinal oximetry was performed using the Oxymap T1 before, 1 month, and 6 months after surgery. Oxymap T1 simultaneously captures monochrome images of the fundus at two different wavelengths of light. Built-in Oxymap Analyzer software measures the oxygen saturation and vessel diameter.Entities:
Keywords: oxygen saturation; retinal vessels; vitrectomy; vitreomacular disease
Year: 2017 PMID: 28461738 PMCID: PMC5408942 DOI: 10.2147/OPTH.S132392
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Fundus images at two different wavelengths of light obtained by Oxymap T1 and the oxygen saturation map analyzed by Oxymap Analyzer.
Notes: Oxymap T1 simultaneously captures 50° monochrome images centered at the optic disk at two different wavelengths of light (570 nm and 600 nm): (A) 570 nm is the reference isosbestic wavelength that is insensitive to oxygen concentration and (B) 600 nm is the oxygen-sensitive wavelength. (C) Oxymap Analyzer automatically calculates the oxygen saturation in each selected vessel and produces a color oxygen saturation map. Retinal vessels with higher oxygen saturation are indicated with red to orange color. Green to purple color indicates the retinal vessels with lower oxygen saturation. (D) For the analysis, vessel selection was performed disk-centered, 1.5-disk to 3-disk diameter area, and 1 disk diameter away from the disk margin.
Systemic and ocular characteristics of recruited population
| Initial recruitment (n=79) | Final recruitment (n=53) | |
|---|---|---|
| Age, years (mean ± standard deviation, range) | 70.6±7.1 (47 to 86) | 68.2±6.9 (47 to 86) |
| Gender, male/female | 32/47 | 17/36 |
| Eye side, right/left | 38/41 | 25/28 |
| Disease type, ERM/MH | 61/18 | 38/15 |
| BCVA, logMAR | 0.317±0.221 | 0.312±0.241 |
| Intraocular pressure, mmHg | 15.8±3.0 | 15.5±2.8 |
| Refractive sphere, diopter (mean ± standard deviation, range) | −0.04±1.74 (−3.75 to +3.5) | 0.08±1.74 (−3.75 to +3.25) |
| Axial length, mm | 23.7±1.1 | 23.6±1.1 |
| Overall image quality in Oxymap Analyzer (mean ± standard deviation, range) | 6.4±0.9 (4.2 to 8.5) | 6.9±0.6 (6.0 to 8.5) |
Abbreviations: ERM, epiretinal membrane; MH, macular hole; BCVA, best-corrected visual acuity.
Oxygen saturation in major retinal vessels before the surgery and 1 month and 6 months after the surgery
| Before surgery | 1 month | 6 months | |
|---|---|---|---|
| Arterial saturation | |||
| Overall (n=53) | 96.3±6.2 | 99.5±5.0 | 99.0±5.7 |
| ERM (n=38) | 95.8±6.8 | 98.9±5.5 | 98.6±6.3 |
| MH (n=15) | 97.5±4.5 | 101.2±2.4 | 100.2±3.6 |
| Venous saturation | |||
| Overall (n=53) | 54.1±7.7 | 61.1±6.2 | 63.1±5.5 |
| ERM (n=38) | 53.7±8.3 | 62.4±6.2 | 63.3±5.5 |
| MH (n=15) | 55.0±5.7 | 57.7±4.8 | 62.5±5.6 |
| A-V different saturation | |||
| Overall (n=53) | 42.2±6.9 | 38.4±7.2 | 36.0±5.4 |
| ERM (n=38) | 42.2±7.7 | 36.5±5.7 | 35.3±5.7 |
| MH (n=15) | 42.4±4.4 | 43.5±5.0 | 37.6±4.4 |
Notes: Data presented as mean ± SD. Unit: %.
P<0.05,
P<0.01, compared with preoperative values (Wilcoxon test with Bonferroni correction).
Abbreviations: ERM, epiretinal membrane; MH, macular hole; A-V, arteriovenous.
Figure 2Oxygen saturation in major retinal vessels before the surgery and 1 month and 6 months after the surgery.
Notes: Left graph: overall subjects; center graph: ERM subject; right graph: MH subject. Upper solid line: arterial saturation; middle solid line: venous saturation; lower broken line: A-V difference. *P<0.05, **P<0.01 compared before surgery.
Abbreviations: ERM, epiretinal membrane; MH, macular hole; A-V, arteriovenous; m, months.
Vessel diameter before the surgery and 1 month and 6 months after the surgery
| Vessel diameter | Before surgery | 1 month | 6 months |
|---|---|---|---|
| Arterial diameter | |||
| Overall (n=53) | 125.2±15.2 | 121.7±14.0 | 124.0±15.4 |
| ERM (n=38) | 125.6±13.9 | 122.8±12.8 | 125.1±14.8 |
| MH (n=15) | 124.3±18.7 | 119.0±17.1 | 121.3±17.0 |
| Venous diameter | |||
| Overall (n=53) | 168.7±14.6 | 170.3±13.3 | 169.8±14.6 |
| ERM (n=38) | 167.8±14.3 | 170.4±14.2 | 170.0±14.9 |
| MH (n=15) | 170.8±15.7 | 170.0±11.3 | 169.3±14.3 |
Notes: Data presented as mean ± SD. Unit: μm.
P<0.05 compared with preoperative values (Wilcoxon test with Bonferroni correction).
Abbreviations: ERM, epiretinal membrane; MH, macular hole.
Figure 3Vessel diameter before the surgery and 1 month and 6 months after the surgery.
Notes: Left graph: overall subjects; center graph: ERM subject; right graph: MH subject. Upper broken line: vein; lower solid line: artery. *P<0.05 compared before surgery.
Abbreviations: ERM, epiretinal membrane; MH, macular hole; m, months.